China Meheco Group Co., Ltd. (SHA:600056)
China
· Delayed Price · Currency is CNY 10.40
+0.12 (1.17%)
Apr 29, 2026, 1:45 PM CST
China Meheco Group Revenue
In the year 2025, China Meheco Group had annual revenue of 35.36B CNY with 3.55% growth. China Meheco Group had revenue of 9.47B in the quarter ending December 31, 2025, with 12.26% growth.
Revenue
35.36B
Revenue Growth
+0.34%
P/S Ratio
0.43
Revenue / Employee
4.23M
Employees
8,368
Market Cap
15.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 35.36B | 1.21B | 3.55% |
| Dec 31, 2024 | 34.15B | -4.68B | -12.04% |
| Dec 31, 2023 | 38.82B | 1.23B | 3.28% |
| Dec 31, 2022 | 37.59B | 1.36B | 3.75% |
| Dec 31, 2021 | 36.23B | -3.08B | -7.83% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Liaoning Cheng Da | 9.90B |
| Qingdao Baheal Medical INC. | 7.58B |
| China National Accord Medicines Corporation | 72.95B |
| China National Medicines Corporation | 53.31B |
| C.Q. Pharmaceutical Holding | 82.27B |
| Jointown Pharmaceutical Group | 157.71B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.66B |
| Guangxi LiuYao Group | 20.95B |